Bioengineering solutions for manufacturing challenges in CAR T cells NJ Piscopo, KP Mueller, A Das, P Hematti, WL Murphy, SP Palecek, ... Biotechnology journal 13 (2), 1700095, 2018 | 84 | 2018 |
Temporal impact of substrate mechanics on differentiation of human embryonic stem cells to cardiomyocytes LB Hazeltine, MG Badur, X Lian, A Das, W Han, SP Palecek Acta biomaterialia 10 (2), 604-612, 2014 | 81 | 2014 |
A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies K Wang, Y Liu, J Li, B Wang, R Bishop, C White, A Das, AD Levine, L Ho, ... Cytotherapy 21 (10), 1081-1093, 2019 | 40 | 2019 |
The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL MH Forsberg, A Das, K Saha, CM Capitini Therapeutics and clinical risk management, 1573-1584, 2018 | 29 | 2018 |
Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression KP Mueller, NJ Piscopo, MH Forsberg, LA Saraspe, A Das, B Russell, ... Journal for immunotherapy of cancer 10 (9), 2022 | 27 | 2022 |
The social production of evidence: regenerative medicine and the 21st Century Cures Act LF Hogle, A Das Regenerative Medicine 12 (6), 581-586, 2017 | 18 | 2017 |
Epidermal growth factor mediated healing in stem cell-derived vocal fold mucosa L Palencia, A Das, SP Palecek, SL Thibeault, C Leydon Journal of Surgical Research 197 (1), 32-38, 2015 | 18 | 2015 |
Improving efficiency of human pluripotent stem cell differentiation platforms using an integrated experimental and computational approach JA Selekman, A Das, NJ Grundl, SP Palecek Biotechnology and bioengineering 110 (11), 3024-3037, 2013 | 13 | 2013 |
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases J Carlson-Stevermer, A Das, AA Abdeen, D Fiflis, BI Grindel, S Saxena, ... Nature communications 11 (1), 6277, 2020 | 10 | 2020 |
Fairness in manufacturing cellular therapies A Das, K Saha, PN Ossorio The American Journal of Bioethics 18 (4), 68-70, 2018 | 3 | 2018 |
Diagnosis of neurocysticercosis by enzyme-linked immunosorbent assay. A Das, R Goyal, S Saxena, NP Singh Journal of the Indian Medical Association 103 (10), 528-529, 2005 | 2 | 2005 |
Kinetics and potency of T cell and CAR-T cell mediated cytolysis of glioma stem cells HB Hayes, MT Logun, SA Chvatal, K Mueller, N Piscopo, A Das, K Saha, ... Cancer Research 81 (13_Supplement), 1552-1552, 2021 | 1 | 2021 |
GD2 CAR-T cells engineered using retroviral transduction or CRISPR editing exhibit strong cytolytic potency against glioma stem cells SA Chvatal, MT Logun, DD Sullivan, HB Hayes, D Millard, MP Katie, ... Cancer Research 82 (12_Supplement), 2817-2817, 2022 | | 2022 |
Chromatin Modulation Improves CRISPR Gene Editing in Human Pluripotent Stem Cells K Molugu, N Khajanchi, CR Lazzarotto, K Gimse, A Das, SQ Tsai, K Saha MOLECULAR THERAPY 30 (4), 95-95, 2022 | | 2022 |
Production and Characterization of Virus-Free, CRISPR-CAR T Cells Capable of Inducing Solid Tumor Regression K Saha, K Mueller, N Piscopo, M Forsberg, L Saraspe, A Das, B Russell, ... MOLECULAR THERAPY 30 (4), 522-523, 2022 | | 2022 |
Nonviral generation of genome edited chimeric antigen receptor t cells K Saha, CM Capitini, KP Mueller, NJ Piscopo, A Das, MH Forsberg, ... US Patent App. 17/407,606, 2022 | | 2022 |
Virus-Free CRISPR CAR T cells induce solid tumor regression LE Sarko, KP Mueller, NJ Piscopo, MH Forsberg, LA Saraspe, A Das, ... | | 2022 |
GD2 CAR-T Cells exhibit strong cytolytic potency against glioma stem cells HB Hayes, MT Logun, SA Chvatal, KP Mueller, NJ Piscopo, A Das, ... The Journal of Immunology 206 (1_Supplement), 58.05-58.05, 2021 | | 2021 |
Design of Efficacious Somatic Cell Genome Editing Strategies for Recessive and Polygenic Diseases A Das, J Carlson-Stevermer, A Abdeen, D Fiflis, B Grindel, S Saxena, ... MOLECULAR THERAPY 29 (4), 204-205, 2021 | | 2021 |
Virus-Free Biomanufacturing of CAR T Cell Products Using CRISPR-Cas9 K Mueller, N Piscopo, M Forsberg, L Saraspe, A Das, B Russell, A Ali, ... MOLECULAR THERAPY 29 (4), 303-303, 2021 | | 2021 |